Comet assay kit and choosing between assay kits by what each can be asked

A kit is a validated recipe for one endpoint in one matrix, and its validity ends where those assumptions do. The recurring failures are using a kit outside its matrix, ignoring interference from the sample, and treating a proxy endpoint as the thing it stands in for.

the biosafety manual that decides handling for biological material
BMBL
good laboratory practice for nonclinical studies, 21 CFR
Part 58
the labelling clause behind research use only on a reagent
809.10(c)

The figures in this panel are regulation and standard identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a price index it has not measured.

Choosing and validating a kit

  1. Match the endpoint to the question. Metabolic activity, membrane integrity, cell number and strand breaks are different endpoints that behave differently. Choosing by convenience produces a number that answers a question nobody asked.
  2. Check the matrix the kit was validated in. A kit validated in buffer or serum may not work in lysate, medium or a process intermediate. Ask what matrix the validation used and run a spike recovery in yours.
  3. Test for interference explicitly. Coloured compounds, high protein, chelators and inhibitors all interfere. A compound only control without cells, and a spiked sample, detect most of it in one plate.
  4. Understand the standard. Every quantitative kit reports relative to its standard, and standards differ between suppliers. Switching kit changes the numbers, and comparing across kits needs a bridging experiment.
  5. Run scored assays blind and to a rule. Assays scored by eye or by image analysis depend heavily on the rule and the scorer. Fix the rule, score blind, and report both.
  6. Keep schedule assays on a schedule. Contamination screening is only useful before the results depend on it. Testing when something looks wrong means the affected experiments are already done.

Kits carry assumptions

A kit encodes a validation that someone else did, in a matrix that may not be yours, against a standard you did not choose. Using it inside those assumptions is efficient; using it outside them silently is where results go wrong.

Read the insert for the matrix and the standard before the protocol. Those two fields decide whether the kit answers your question.

Interference is checked in one plate

A compound only control, a matrix blank and a spiked recovery together detect almost every interference that matters, and they fit on one plate alongside the first real experiment.

Doing it once per new sample type converts a recurring source of confusion into a known property.

A catalase assay kit, and what it measures

Catalase activity is measured either by following hydrogen peroxide disappearance directly, usually at 240 nanometres, or by a coupled colourimetric or fluorescent reaction on the peroxide that remains. The second is what most plate kits use, and it is an endpoint, so the incubation time and the enzyme amount have to put the reading in the linear part of the curve. Samples are handled cold and read fresh, since the enzyme is abundant and active enough that a slow assay consumes its substrate before the plate is read.

An ethanol assay kit, and what it measures

Ethanol assays are enzymatic: alcohol dehydrogenase oxidises ethanol and the reduced cofactor is read by absorbance or coupled to a colourimetric or fluorescent probe. Specificity comes from the enzyme, but other short chain alcohols react to some extent, so a sample carrying methanol or isopropanol reads high. Volatility is the practical trap, since ethanol leaves an open tube and a warm plate measurably, which is why samples are capped, kept cold and read promptly against a standard curve made the same day.

A protease assay kit and what it measures

A protease assay kit measures activity rather than protein, usually by releasing a fluorophore from a peptide substrate, so the substrate's specificity is what decides whether the reading is the enzyme of interest or every protease in the sample. An inhibitor control on the same plate is what makes the number attributable.

A seap assay and the reporter behind it

A seap assay reads a secreted alkaline phosphatase reporter in the medium rather than in a lysate, which means the same culture can be sampled repeatedly over time instead of being destroyed at one point. Endogenous phosphatase is the background to control for, usually by heat inactivation of the sample.

A massively parallel reporter assay and what it tests

A massively parallel reporter assay puts thousands of candidate regulatory sequences in front of a barcoded reporter in one pool, so the effect of each is read by sequencing rather than by separate measurements. The library design and the barcode counting statistics are the whole experiment, and coverage per element is what makes an effect readable.

custom assay development, and what a brief has to state

custom assay development starts from the decision the assay will support, which sets the required precision, the range and the acceptable false call rate, and those three rather than the technique are what a brief has to state. An assay developed without a stated precision target cannot be said to have been delivered.

Common questions

Why do two kits give different numbers?
Different standards and different endpoints. Both can be internally correct, which is why a study should fix one kit and state it rather than mixing them.
What does an endotoxin assay need before a sample?
An inhibition and enhancement test in your matrix, showing that a spiked known amount is recovered. Without it a low result cannot be distinguished from a suppressed assay.
Are cell proliferation assays measuring cells?
Usually it measures metabolic activity, which tracks cell number only when metabolism per cell is constant. Compounds that affect metabolism directly break that assumption.

Get a shortlist for your project

Free. We send a shortlist of vendors whose published prices and service scope fit what you described, built from the verified index on this site. We may email you about this enquiry and similar services from this site; opt out any time, including from the first message.

Browse by service class

Sources

Cite or embed this figure

The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.

Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/comet-assay-kit/.

Embed this figure (plain HTML, no scripts)
median advertised gene synthesis price per base pair · the US research synthesis services market · August 2026

$0.11

Middle 50%$0.07 – $0.15
verified vendor service pages4

Source: BioBricks Synthesis Price Index

Get a vendor shortlistCompare synthesis prices